Boston Partners’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$100M Buy
1,494,024
+417,231
+39% +$30.5M 0.09% 223
2026
Q1
$82.1M Buy
+1,076,793
New +$77.6M 0.09% 226
2019
Q2
Sell
-30,772
Closed -$2.33M 675
2019
Q1
$2.33M Buy
+30,772
New +$2.45M ﹤0.01% 522
2017
Q2
Sell
-7,500
Closed -$606K 751
2017
Q1
$606K Buy
+7,500
New +$590K ﹤0.01% 718
2016
Q1
Sell
-43,352
Closed -$2.93M 721
2015
Q4
$2.93M Sell
43,352
-25,508
-37% -$1.78M ﹤0.01% 556
2015
Q3
$4.46M Sell
68,860
-15,436
-18% -$1.14M 0.01% 500
2015
Q2
$6.9M Buy
+84,296
New +$6.5M 0.01% 451

Other funds holding EMN

Boston Partners's EMN Position: Q2 2026 in Review

Boston Partners increased its Eastman Chemical (EMN) stake by 39% in Q2 2026, buying an estimated $30.5M and bringing the position to 1,494,024 shares worth $100M. The position accounts for 0.09% of the portfolio, ranked #223.

Boston Partners first reported a position in EMN in Q2 2015 and has held it in 7 quarters since. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Boston Partners held 1,494,024 shares of Eastman Chemical worth $100M as of Q2 2026.
  • Boston Partners bought 417,231 Eastman Chemical shares in Q2 2026, an estimated $30.5M.
  • Eastman Chemical made up 0.09% of Boston Partners's portfolio in Q2 2026, its #223 holding.
  • Boston Partners first reported a position in Eastman Chemical in Q2 2015 and has held it in 7 quarters since.
  • 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.